Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01501838 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pulmonary Hypertension Institutional Registry at Hospital Italiano de Buenos Aires

Study acronym: PH-HIBA
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Trial status: Withdrawn to Recruitingv6 Show 9 more changesShow less
    • Primary completion date: Dec 2020 to Dec 31, 2030
    • Start date: Dec 2010 to Jan 1, 2017
    • Primary endpoints: 1 to 2
    • Enrollment target: 0 to 200
    • Study completion date: Dec 2020 to Jun 1, 2031
    • Eligibility criteria expanded, about 51 words
    • Site details revised
    • Study title expanded, about 6 words
    • Study description shortened, about 4 words
  2. Notable Trial status: Suspended to Withdrawn
    • Enrollment target: estimated 100000 to confirmed 0
    v5
  3. Stopped Trial status: Recruiting to Suspended Sponsor's reason: By the moment nvestigators are not recuiting because logistics issues
    • Site details revised
    v4
  4. Minor Re-verified, no change to tracked fieldsv3
  5. Minor Primary and study completion dates: Dec 2020v2
  6. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to create a registry of patients with Pulmonary Hypertension who received medical care in the Hospital Italiano of Buenos Aires.
Trial Details
NCT Number NCT01501838
Lead Sponsor Hospital Italiano de Buenos Aires
Conditions
(from sponsor)
Hypertension, Pulmonary Arterial
Related terms Pulmonary Arterial Hypertension
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov